Lighthouse Investment Partners LLC acquired a new stake in shares of ZimVie Inc. (NASDAQ:ZIMV – Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 92,700 shares of the company’s stock, valued at approximately $1,692,000. Lighthouse Investment Partners LLC owned approximately 0.34% of ZimVie as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also bought and sold shares of ZIMV. Gabelli Funds LLC raised its position in ZimVie by 2.0% in the first quarter. Gabelli Funds LLC now owns 41,060 shares of the company’s stock valued at $677,000 after purchasing an additional 800 shares during the last quarter. Price T Rowe Associates Inc. MD raised its holdings in ZimVie by 6.3% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,531 shares of the company’s stock valued at $356,000 after buying an additional 1,275 shares during the last quarter. Scarborough Advisors LLC bought a new position in ZimVie in the 4th quarter valued at approximately $28,000. Russell Investments Group Ltd. boosted its position in ZimVie by 0.7% during the 1st quarter. Russell Investments Group Ltd. now owns 281,377 shares of the company’s stock worth $4,640,000 after buying an additional 1,964 shares during the period. Finally, Summit Securities Group LLC grew its holdings in ZimVie by 518.6% during the 2nd quarter. Summit Securities Group LLC now owns 3,000 shares of the company’s stock worth $55,000 after acquiring an additional 2,515 shares during the last quarter. Institutional investors own 95.63% of the company’s stock.
Insider Activity
In other news, major shareholder Camber Capital Management Lp sold 525,000 shares of the stock in a transaction on Friday, August 2nd. The shares were sold at an average price of $17.71, for a total transaction of $9,297,750.00. Following the completion of the sale, the insider now directly owns 2,725,000 shares in the company, valued at $48,259,750. The transaction was disclosed in a filing with the SEC, which is available at this link. Insiders own 3.01% of the company’s stock.
ZimVie Trading Up 1.1 %
ZimVie (NASDAQ:ZIMV – Get Free Report) last posted its quarterly earnings data on Thursday, August 1st. The company reported $0.13 EPS for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.04). The company had revenue of $116.81 million during the quarter. ZimVie had a positive return on equity of 2.21% and a negative net margin of 63.84%. During the same quarter in the prior year, the company posted $0.17 earnings per share. On average, analysts expect that ZimVie Inc. will post 0.63 EPS for the current year.
Analyst Ratings Changes
Separately, Needham & Company LLC raised their price target on shares of ZimVie from $20.00 to $23.00 and gave the company a “buy” rating in a research note on Friday, August 2nd.
View Our Latest Stock Report on ZIMV
ZimVie Company Profile
ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.
See Also
- Five stocks we like better than ZimVie
- When to Sell a Stock for Profit or Loss
- CarMax’s Impressive Rally: What Investors Should Watch Next
- Best Aerospace Stocks Investing
- MarketBeat Week in Review – 9/23 – 9/27
- How to Invest in Insurance Companies: A Guide
- Wake Up to This Biotech Stock That Still Has Big Potential Upside
Want to see what other hedge funds are holding ZIMV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ZimVie Inc. (NASDAQ:ZIMV – Free Report).
Receive News & Ratings for ZimVie Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZimVie and related companies with MarketBeat.com's FREE daily email newsletter.